GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business. The FDA approved the ...

GlaxoSmithKline looks set to have another year without US generic competition to its respiratory blockbuster Advair, after the FDA raised problems with a challenger. Reuters reports today that ...

Angelica Leicht is a seasoned personal finance writer and editor with nearly two decades of experience but just one goal: to help readers make the best decisions for their wallets. Her expertise spans ...

Showcase your company news with guaranteed exposure both in print and online Get ready for the annual Columbus Business First Power Breakfast… Where Ambition Finds Direction Join us as we celebrate ...

Frisco, Texas — December 15, 2025 — PSBP Law is pleased to announce the opening of its… Goranson Bain Ausley (GBA), the largest family law firm in Texas, is expanding its Fort… Please join the Dallas ...

Scheduled for completion in 2027, the 192,000-square-foot facility, made with glue-laminated timber, is expected to be one of the largest cross-laminated timber manufacturing plants in the U.S. A look ...

2 Auxiliary Fuel Tanks (ACTs) for over 4000 nm of range non-stop (Middle East to Europe - Europe to US East Coast – Asia to Middle East) ...